Independent assessment supports a role for tamoxifen in breast cancer risk reduction

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY-NEW YORK | 1999年 / 13卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1211 / 1211
页数：1
相关论文
共 50 条
  • [11] Risk/benefit assessment of tamoxifen to prevent breast cancer - Still a work in progress?
    Taylor, AL
    Adams-Campbell, LL
    Wright, JT
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (21) : 1792 - 1793
  • [12] Role of dietary lignans in the reduction of breast cancer risk
    Saarinen, Niina M.
    Warri, Anni
    Airio, Maarit
    Smeds, Annika
    Makela, Sari
    MOLECULAR NUTRITION & FOOD RESEARCH, 2007, 51 (07) : 857 - 866
  • [13] Will a Low-Dose Option Improve Uptake of Tamoxifen for Breast Cancer Risk Reduction?
    Fabian, Carol J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (19)
  • [14] COST EFFECTIVENESS ANALYSIS OF BREAST CANCER RISK REDUCTION THERAPY: COMPARING TAMOXIFEN AND RALOXIFENE
    Poon, J. L.
    Hay, J.
    VALUE IN HEALTH, 2010, 13 (03) : A37 - A37
  • [15] Tamoxifen therapy for breast cancer and endometrial cancer risk
    Bernstein, L
    Deapen, D
    Cerhan, JR
    Schwartz, SM
    Liff, J
    McGann-Maloney, E
    Perlman, JA
    Ford, L
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (19) : 1654 - 1662
  • [16] Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer
    Li, CI
    Malone, KE
    Weiss, NS
    Daling, JR
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (13) : 1008 - 1013
  • [17] Tamoxifen for women at high risk of breast cancer
    Nazarali, Safia A.
    Narod, Steven A.
    BREAST CANCER-TARGETS AND THERAPY, 2014, 6 : 29 - 36
  • [18] Fracture risk with tamoxifen in postmenopausal breast cancer
    Short, R
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (01) : 4 - 4
  • [19] New data on breast cancer risk with tamoxifen
    Reactions Weekly, 2009, 1276 (1) : 3 - 3
  • [20] Stroke risk and tamoxifen therapy for breast cancer
    Geiger, AM
    Fischberg, GM
    Chen, WS
    Bernstein, L
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (20): : 1528 - 1536
12345